logging in or signing up physicochemical property of new drug molecule bhvkbhtt Download Post to : URL : Related Presentations : Let's Connect Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Copy embed code: Embed: Flash iPad Dynamic Copy Does not support media & animations Automatically changes to Flash or non-Flash embed WordPress Embed Customize Embed URL: Copy Thumbnail: Copy The presentation is successfully added In Your Favorites. Views: 1526 Category: Entertainment License: All Rights Reserved Like it (2) Dislike it (0) Added: November 20, 2010 This Presentation is Public Favorites: 2 Presentation Description No description available. Comments Posting comment... By: Shambhu12 (31 month(s) ago) it is superb &informative Saving..... Post Reply Close Saving..... Edit Comment Close By: kedarlaxman (37 month(s) ago) superb and useful presentation and it covers all points Saving..... Post Reply Close Saving..... Edit Comment Close By: yarlagadda.manoj1 (38 month(s) ago) super nd useful presentation Saving..... Post Reply Close Saving..... Edit Comment Close Premium member Presentation Transcript Slide 1: A seminar on Preformulation Studies:Physicochemical characterization of new drug molecules Presented By:- BHATT BHAVIK R. 1st M- Pharm. Department of Pharmaceutics. NGSM IPS, Mangalore 1 Slide 2: CONTENTS INTRODUCTION OBJECTIVES PREFORMULATION STUDIES PHYSICOCHEMICAL CHARACTERISATIONS ANALYTICAL MEASURES CONCLUSION REFERENCES 11/20/2010 2 Slide 3: INTRODUCTION Preformulation testing is the first step in the rational development of dosage forms. It can be defined as an investigation of physical and chemical property of a drug substance alone and when combined with excipients. Physiochemical properties are those that can be determined from in vitro experiments. 11/20/2010 3 Slide 4: OBJECTIVES The main objective is to generate information useful to the formulation in developing most stable and bioavailable dosage form that mass can be produced. 11/20/2010 4 Slide 5: Why is Preformulation Important ? It describes the process of optimizing the delivery of drug thorough determination of physical, chemical properties of new drug molecule that affect drug performance and development of an efficacious stable and safe dosage form. Preformulation studies on a new drug molecule provide useful information for subsequent formulation of a physicochemically stable and biopharmaceutically suitable dosage form. 11/20/2010 5 PHYSICOCHEMICAL PROPERTIES : 1. BULK PROPERTIES Bulk properties of the solid form such as crystallinity, polymorphism, particle size, powder flow property, and surface characteristics are likely to change during process development. Crystallinity The crystal habit describes the outer appearance of crystals ( platy, equant, needle, bladed, etc.) and internal structure arrangement. Compounds have several different habits, depending on the environment for growing crystals. PHYSICOCHEMICAL PROPERTIES 11/20/2010 6 Slide 7: Polymorphism polymorphism is the ability of the compound to crystallize as more than one distinct crystalline species with different internal structure. Formation of different polymorphs depends on solvents, temperature, pressure, rate of cooling, etc. Polymorphic transitions can also occur during milling, granulating, drying and compressing operations Different polymorphs vary in physical properties such as dissolution, solid-state stability, compatibility, etc 11/20/2010 7 Slide 8: Particle size Study of particle size give an information about solubility, dissolution rate, absorption, etc. particle size and surface area of a solid drug are inversely related to each other. eg: Griseofulvin Powder flow property The flow properties of a powder will determine the nature and quantity of excipients needed to prepare a compressed or a powder dosage form. This refers mainly to factors such as the ability to process the powder through machines. 11/20/2010 8 Slide 9: HYGROSCOCITY The tendency of a solid to take up water from the atmosphere, as it is subjected to a controlled RH program under isothermal condition i.e. hygroscopicity. Classified based on the amount of rate of water uptake when a solid is exposed to controlled RH value at a specified temperature. 11/20/2010 9 SOLUBILITY ANALYSIS : 1. AQUEOUS SOLUBILITY Important goal of the preformulation effort is to devise a method for making solutions of the drug Orally administered drug must dissolve in the aqueous fluid of the GIT prior to absorption. Solubility can be improved by addition of cosolvents. Solubilities cannot be determined by precipitative methods. SOLUBILITY ANALYSIS 11/20/2010 10 Slide 11: 2. Drug pKa / Ionization at physiological pH pKa is the dissociation constant of a drug. The nonionized substances is lipid soluble thus dissolve in lipid material of the membrane and transported by passive diffusion. Where as, the ionized substances is a lipid insoluble therefore permeation is slow. 11/20/2010 11 Slide 12: The percentage of ionization can be calculated as … For Acidic compounds: For Basic compounds: Degree of ionization depends up on the pH. for acidic drugs pKa ranges from 3-7.5. for basic drugs pKa ranges from 7-11. % ionized = 100/ 1+ antilog (pH – pKa) % ionized = 100/ 1+ antilog (pKa – pH) 11/20/2010 12 Slide 13: 3. PARTITION COEFFICIENT Partition coefficient influence permeation of a drug across biological membrane. Partition coefficient is a ratio of equilibrium concentration of drug in oil phase to equilibrium concentration of drug in aqueous phase . where, Co-organic phase concentration Cw-aqueous phase concentration K=Co/Cw 11/20/2010 13 Slide 14: Following administration, the drug must travel through a variety of membranes to gain access to the target area. Drug with extremely high partition co-efficient (i.e. very oil-soluble ) readily penetrate the membranes. While drugs with excessive aqueous solubility i.e. low oil/water partition co-efficient cannot penetrate the membrane. 11/20/2010 14 Slide 15: DISSOLUTION To know the gastrointestinal absorption & other physicochemical properties. The intrinsic dissolution rate is determined by the rotating disc method. The dissolution rate is described by Noyes-Whiteny equation. Intrinsic dissolution Paricular dissolution 11/20/2010 15 STABILITY ANALYSIS : DRUG STABILITY In this study includes both solutions and solid-state experiments under various conditions for handling, formulation, storage, and in vivo administration. solution phase stability: The effect of pH on stability is important in the development of both oral and Parenteral dosage forms Acid sensitive drugs protected from highly acidic environment of the stomach by coating it with suitable polymers. Solid phase stability depends on several factors like temperature, pH, humidity, hydrolysis, oxidation, etc… STABILITY ANALYSIS 11/20/2010 16 Slide 17: COMPATIBILITY Compatibility test play a very important role in the preformulation studies of oral dosage forms. Problems arise because of the interaction with other drug substances and with preservatives, stabilizers, dyes, and flavors. It is important for the formulator of a new drug substance to know with which excipients he can work and which he cannot. 11/20/2010 17 Slide 18: ANALYTICAL MEASURES Various analytical techniques are available for the investigation of the physicochemical properties and determination of impurity of new drug molecules. These includes: Microscopy Spectroscopy Chromatography 11/20/2010 18 Slide 19: A. MICROSCOPY: In this technique substances are examined under the microscope. It gives information about shape, thickness, particle size, etc. of drug molecules. By this method we can study crystal morphology, difference between polymorphic character of molecule. 11/20/2010 19 Slide 20: B. SPECTROSCOPY UV and Visible Spectrophotometry When organic molecules in solution, or as liquid, are exposed to light in the visible and ultraviolet light regions of spectrum, they absorb light of particular wavelengths depending on the type of electronic transition that is associated with the absorption. The electronic transitions depends on the electron bonding with in the molecule. Spectrophotometry can be used to study to enzyme reaction and to evalute the effect of drug on enzyme. UV study of compounds gives information regarding unsaturation of compounds. 11/20/2010 20 Slide 21: IR Spectroscopy The study of the interaction of electromagnetic radiation with vibrational and rotational resonances within a molecular structure is termed as IR Spectroscopy. IR has the ability to differentiate isomers groups such as Cis-trans double bond compound. Gives an information regarding functional group present in new drug molecule. FT-IR use for both qualitative and quqntitative analysis of sample. 11/20/2010 21 Slide 22: X-RAY DIFFRACTION When a beam of non homogenous x-rays is allowed to pass through a sample the x-ray beam is diffracted & it is recorded by means of photographic plates . Single Crystal X-ray provides the most complete information about the solid state. It is used to differentiate the amophous and crystalline forms. This method is tedious, time consuming & hence unsuitable for routine use. 11/20/2010 22 Slide 23: Thermal Analysis Differential scanning calorimetry (DSC) and differential thermal analysis(DTA) are particularly useful in preformulation studies including purity, polymorphism, solvation, degradation, and excipient compatibility. It measures physical or chemical changes of drug molecules. Thermigravimetric analysis Used to detect the existange and stability of solvated drug molecule. 11/20/2010 23 Slide 24: C. CHROMATOGRAPHY In the preformulation studies, chromatographic techniques such as TLC, HPLC,GC carrying a major role. The major advantages are direct analysis of aqueous samples, high sensitivity, and specific determination of drug concentration, separation of drug from impurities or degradation products. Analytical data from TLC may be required to precisely determine the kinetics of decomposition. HPLC and GC are useful for solubility measurements. 11/20/2010 24 Slide 25: CONCLUSION Preformulation studies on a new drug molecule provide useful information for subsequent formulation of a Physicochemically stable and Biopharmaceutically suitable dosage form. Thorough Preformulation work is the foundation of developing efficacious and economical formulations. 11/20/2010 25 Slide 26: REFERENCES Banker GS, Rhodes CT., Modern pharmaceutics, 4th ed. New York: Marcel Dekker; 2002. p.167-184 Alfred Martin., Physical pharmacy. 4th ed. New York: Lippincott Williams & Wilkins; 2001. p. 77-100 Remington, The Science and Practice of Pharmacy, 20th Edition, B.I Publication Pvt Ltd.p.940-42 Leon Lachman, Herbert AL, Joseph LK., The theory and practice of industrial pharmacy, 3rd ed. Bombay: Varghese publishing house; 1990. p. 171- 196 11/20/2010 26 Slide 27: Thank you …. 11/20/2010 27 You do not have the permission to view this presentation. In order to view it, please contact the author of the presentation.